search
Back to results

BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease (BEWARE)

Primary Purpose

Parkinsonism, Experimental, Parkinsonism, Treatment as Usual

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Body awareness therapy
Physical therapy
Sponsored by
Amsterdam UMC, location VUmc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinsonism, Experimental focused on measuring Body awareness therapy, Physical therapy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of idiopathic Parkinson's Disease
  • Experiencing Wearing-off
  • Experiencing anxiety (BAI > 27)

Exclusion Criteria:

  • Dementia (MMSE < 22)
  • Other neurologic, orthopedic, cardiopulmonary problems that may interfere with participation

Sites / Locations

  • VU Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Body awareness therapy

Treatment as Usual

Arm Description

The experimental treatment: BEWARE

The new treatment is compared to this arm: Physical therapy

Outcomes

Primary Outcome Measures

Self-efficacy
how the patients can live their lives without being controlled by their disease, measured with the General Self Efficacy Scale
Self-efficacy
how the patients can live their lives without being controlled by their disease, measured with the General Self Efficacy Scale

Secondary Outcome Measures

Anxiety
measured with the Beck Anxiety Inventory
Depression
measured with the Beck Depression Inventory
Balance performance
measured with the One Leg Stance test
comfortable walking speed
measured with the 10 Meter Walk Test
Quality of life
measured with the Parkinson's Disease Questionnaire - 39
Wearing-off symptoms
Assessing wearing-off related symptoms with the Wearing-off Questionnaire - 19
Activities of Daily Living independence
measured with the Nottingham Extended Activities of Daily Living index
Freezing of Gait
To asses an important symptom of Parkinson's disease, we included the Freezing of Gait Questionnaire
Anxiety
measured with the Beck Anxiety Inventory
Depression
measured with the Beck Depression Inventory
Balance performance
measured with the One Leg Stance Test
Comfortable walking speed
measured with the 10 Meter Walk Test
Quality of Life
measured with the Parkinson's Disease Questionnaire - 39
Wearing-off symptoms
assessing wearing-off related symptoms with the Wearing-Off Questionnaire - 19
Activities of Daily Living independence
measured with the Nottingham Extended Activities of Daily Living index
Freezing of gait
to assess an important symptom of Parkinson's Disease, as measured by the freezing of gait questionnaire

Full Information

First Posted
January 30, 2014
Last Updated
February 3, 2014
Sponsor
Amsterdam UMC, location VUmc
Collaborators
Parkinsonvereniging
search

1. Study Identification

Unique Protocol Identification Number
NCT02054845
Brief Title
BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease
Acronym
BEWARE
Official Title
BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's diseasE.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2014 (undefined)
Primary Completion Date
December 2014 (Anticipated)
Study Completion Date
December 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Amsterdam UMC, location VUmc
Collaborators
Parkinsonvereniging

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Approximately 60% of the patients with Parkinson's Disease (PD) that receive Levodopa therapy eventually develop response fluctuations in motor symptoms, such as rigidity, freezing and akinesia. Patients experience an 'off'-period just before the next dose of dopaminergic medication is needed, called the 'wearing-off'-phenomena. Wearing-off is also accompanied by non-motor symptoms such as depression, anxiety, pain and thinking disability. Together, these motor and non-motor symptoms have a major impact on the quality of life of patients and their partner or caregiver. Patients with wearing-off often experience severe anxiety and panic symptoms that are incongruent with the severity of the motor symptoms during an 'off' period. These symptoms include stress, dizziness, pounding/racing of the heart, dyspnoea and hyperventilation. This type of anxiety is called wearing-off related anxiety (WRA) and might be a consequence of the hypersensitivity towards somatic manifestations and effects of a wearing-off period. This bodily misperception can have major consequences for the patient's feelings and behaviour. The experienced anxiety is often not consciously linked to the wearing-off and is therefore not well recognized by neurologists. Treatment as usual in response fluctuations is physiotherapy, consisting of physical exercises for mobility problems, freezing, dyskinesias, etc. This kind of training hardly touches upon the mental aspects and the role of anxiety as integral element of the response fluctuations. Cognitive behaviour therapy (CBT, including exposure in vivo) is sometimes used to treat WRA, but seems to have unsatisfactory results since the changed body awareness is not sufficiently addressed. Also, the methods used in cognitive therapies focus on the elimination of WRA which is often not realistic since wearing-off symptoms will remain or even increase during disease progression. As of yet, there are no known alternative intervention options. This study focuses on a new intervention by integrating elements from physiotherapy, mindfulness, CBT (mainly exposure), Acceptance and Commitment Therapy (ACT) and psycho-education. Objective: The current proposal aims at investigating the effect of a multidisciplinary non-verbal intervention on the awareness and modulation of WRA to improve self-efficacy, mobility, mood, and quality of life as compared to usual care. Study design: Randomized controlled clinical trial. Study population: Thirty-six PD patients who experience WRA. Intervention: Patients with PD are randomly allocated into one of two groups (n= 18 each). One group receives the experimental 'body-awareness therapy', while the second group receives regular group-physiotherapy (treatment as usual). Both interventions will take 6 weeks in which 2 sessions per week with a duration of 1,5 hour will be performed. Main study parameters/endpoints: The General Self-Efficacy Scale is the primary outcome measure and will be assessed prior to, directly after and 18 weeks after the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinsonism, Experimental, Parkinsonism, Treatment as Usual
Keywords
Body awareness therapy, Physical therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Body awareness therapy
Arm Type
Experimental
Arm Description
The experimental treatment: BEWARE
Arm Title
Treatment as Usual
Arm Type
Active Comparator
Arm Description
The new treatment is compared to this arm: Physical therapy
Intervention Type
Behavioral
Intervention Name(s)
Body awareness therapy
Other Intervention Name(s)
BEWARE
Intervention Description
Experimental condition: BEWARE training group The physical and psychosocial elements of the training sessions will be complementary: psychological techniques are used to induce and endure wearing-off and physical techniques are used to improve body awareness to cope with the off-periods. Specifically the following techniques will be applied: Body scan Psychoeducation Acceptance Commitment Therapy / Mindfulness skills (sustained attention, concentration, non-reactivity, nonjudging of experience) Body Awareness Training Exposure training (imaginary exposure to induce response fluctuations) Training in cueing techniques to overcome problems with initiation and freezing Visual Feedback training Relaxation techniques
Intervention Type
Other
Intervention Name(s)
Physical therapy
Other Intervention Name(s)
Treatment as usual
Intervention Description
Control condition: Treatment as Usual The control group will receive treatment as usual based on the current guidelines for physical therapy in patients with Parkinson's Disease, with the same training schedule of 2x per week for 1,5 hours during 6 weeks. Group treatment will contain exercises for balance, walking, posture, transfers, arm/hand dexterity, strength, flexibility, relaxation and physical condition.
Primary Outcome Measure Information:
Title
Self-efficacy
Description
how the patients can live their lives without being controlled by their disease, measured with the General Self Efficacy Scale
Time Frame
Change from baseline in self-efficacy at 6 weeks
Title
Self-efficacy
Description
how the patients can live their lives without being controlled by their disease, measured with the General Self Efficacy Scale
Time Frame
Change from baseline in self-efficacy at 18 weeks
Secondary Outcome Measure Information:
Title
Anxiety
Description
measured with the Beck Anxiety Inventory
Time Frame
Change from baseline in anxiety at 6 weeks
Title
Depression
Description
measured with the Beck Depression Inventory
Time Frame
Change from baseline in depression at 6 weeks
Title
Balance performance
Description
measured with the One Leg Stance test
Time Frame
Change from baseline in balance performance at 6 weeks
Title
comfortable walking speed
Description
measured with the 10 Meter Walk Test
Time Frame
Change from baseline in walking speed at 6 weeks
Title
Quality of life
Description
measured with the Parkinson's Disease Questionnaire - 39
Time Frame
Change from baseline in quality of life at 6 weeks
Title
Wearing-off symptoms
Description
Assessing wearing-off related symptoms with the Wearing-off Questionnaire - 19
Time Frame
Change from baseline in wearing-off symptoms at 6 weeks
Title
Activities of Daily Living independence
Description
measured with the Nottingham Extended Activities of Daily Living index
Time Frame
Change from baseline in independence at 6 weeks
Title
Freezing of Gait
Description
To asses an important symptom of Parkinson's disease, we included the Freezing of Gait Questionnaire
Time Frame
Change from baseline in freezing of gait at 6 weeks
Title
Anxiety
Description
measured with the Beck Anxiety Inventory
Time Frame
Change from baseline in anxiety at 18 weeks
Title
Depression
Description
measured with the Beck Depression Inventory
Time Frame
Change from baseline in depression at 18 weeks
Title
Balance performance
Description
measured with the One Leg Stance Test
Time Frame
Change from baseline in balance performance at 18 weeks
Title
Comfortable walking speed
Description
measured with the 10 Meter Walk Test
Time Frame
Change from baseline in walking speed at 18 weeks
Title
Quality of Life
Description
measured with the Parkinson's Disease Questionnaire - 39
Time Frame
Change from baseline in quality of life at 18 weeks
Title
Wearing-off symptoms
Description
assessing wearing-off related symptoms with the Wearing-Off Questionnaire - 19
Time Frame
Change from baseline in anxiety at 6 weeks
Title
Activities of Daily Living independence
Description
measured with the Nottingham Extended Activities of Daily Living index
Time Frame
Change from baseline in independence at 18 weeks
Title
Freezing of gait
Description
to assess an important symptom of Parkinson's Disease, as measured by the freezing of gait questionnaire
Time Frame
Change from baseline in freezing of gait at 18 weeks
Other Pre-specified Outcome Measures:
Title
Mental state
Description
To decide whether patients have to be excluded from the study, cognitive ability is measured with the Mini Mental State Examination (MMSE)
Time Frame
baseline

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of idiopathic Parkinson's Disease Experiencing Wearing-off Experiencing anxiety (BAI > 27) Exclusion Criteria: Dementia (MMSE < 22) Other neurologic, orthopedic, cardiopulmonary problems that may interfere with participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
O A van den Heuvel, psychiatrist
Organizational Affiliation
Amsterdam UMC, location VUmc
Official's Role
Principal Investigator
Facility Information:
Facility Name
VU Medical Center
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1081 HZ
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
29167034
Citation
Ghielen I, van Wegen EEH, Rutten S, de Goede CJT, Houniet-de Gier M, Collette EH, Burgers-Bots IAL, Twisk JWR, Kwakkel G, Vermunt K, van Vliet B, Berendse HW, van den Heuvel OA. Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial. J Psychosom Res. 2017 Dec;103:1-8. doi: 10.1016/j.jpsychores.2017.09.008. Epub 2017 Sep 21.
Results Reference
derived
PubMed Identifier
26101038
Citation
Ghielen I, van den Heuvel OA, de Goede CJ, Houniet-de Gier M, Collette EH, Burgers-Bots IA, Rutten S, Kwakkel G, Vermunt K, van Vliet B, Berendse HW, van Wegen EE. BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2015 Jun 23;16:283. doi: 10.1186/s13063-015-0804-0.
Results Reference
derived
Links:
URL
http://www.parkinson-beware.nl
Description
information on the BEWARE study

Learn more about this trial

BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease

We'll reach out to this number within 24 hrs